Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+ (Keerthi Vedantam/Crunchbase News)

Keerthi Vedantam / Crunchbase News: Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+  —  This is not your average raise.  —  Biotech upstart Tempus announced on Thursday it raised $275 million through equity …

Oct 23, 2022 - 07:02
182135
Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+ (Keerthi Vedantam/Crunchbase News)

Keerthi Vedantam / Crunchbase News:
Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+  —  This is not your average raise.  —  Biotech upstart Tempus announced on Thursday it raised $275 million through equity …

This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.